Arginine methylation of RUNX1 affects peripheral CD4+ T cells in intact mice

Arginine methylation of RUNX1 affects peripheral CD4+ T cells in intact mice

CH3 BioSystemsRUNX1 (previously termed AML1) is a frequent target of human leukaemia-associated gene aberrations, and it encodes the DNA-binding subunit of the Core-Binding Factor transcription factor complex. RUNX1 expression is essential for the initiation of definitive haematopoiesis, for steady-state thrombopoiesis, and for normal lymphocytes development. Recent studies revealed that protein arginine methyltransferase 1 (PRMT1), which accounts for the majority of the type I PRMT activity in cells, methylates two arginine residues in RUNX1 (R206 and R210), and these modifications inhibit corepressor-binding to RUNX1 thereby enhancing its transcriptional activity.

Read More: http://www.ncbi.nlm.nih.gov/pubmed/26010396

John Aletta
No Comments

Post a Comment